Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
D

Unnecessary Psychotropic Drug Increase Without Proper Orders or Consent

Hayward, California Survey Completed on 04-30-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A deficiency occurred when a resident with schizoaffective disorder and severe cognitive impairment had their Seroquel (Quetiapine) dosage increased from 25 mg twice daily to 50 mg twice daily without a documented physician order, clinical indication, or timely informed consent. The resident's records showed no increase in hallucination episodes to justify the dosage change, and the new order for Seroquel did not match the previously documented indication or monitoring for schizoaffective disorder. The Assistant Director of Nursing (ADON) stated she entered the new order based on a verbal instruction during an interdisciplinary team meeting, but could not find documentation of a physician's order or indication for the increase in the resident's electronic health record. Additionally, the required written informed consent for the psychotropic medication increase was not obtained from the resident's responsible party (RP) until over two months after the medication change was implemented. The consent form remained unsigned by both the RP and the physician during this period, and facility records indicated the RP was available for part of the time when the consent could have been obtained. Facility policy requires that psychotropic medications be clinically indicated, necessary, and supported by documented evaluation and consent, which was not followed in this case.

An unhandled error has occurred. Reload 🗙